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The neural crest is a transient population of cells that 
detach from the top of the neural tube and then dis- 
perse throughout the embryo giving rise to the periph- 
eral nervous system, melanocytes, and the adrenal 
medulla, as well as a diverse array of other cell types. 
Transplantation experiments suggest that most premi- 
gratory cells throughout the neural crest have the same 
developmental potential, regardless of their actual fate 
(LeDouarin 1982; Weston 1982.) Thus, the environ- 
ment encountered by crest cells during or after migra- 
tion appears to be critical in determining their final 
phenotype. 
One neural crest developmental decision that shows 
considerable environmental influence is the choice be- 
tween an endocrine and a neuronal phenotype. Both 
adrenergic endocrine cells (chromaffin cells) of the ad- 
renal medulla and noradrenergic neurons of the para- 
vertebral sympathetic ganglia derive from the so-called 
sympathoadrenal (Landis and Patterson 1981) region 
of the crest, which originates in the caudal thoracic re- 
gion (LeDouarin 1982). Transplantation experiments 
have shown that when this region is removed and re- 
placed by a graft of more rostrally originating crest, 
histologically distinguishable donor-derived chromaf- 
fin cells develop in the adrenal medulla, despite the fact 
that the donor crest normally never gives rise to these 
cells but only to neurons (LeDouarin 1980). Thus, the 
embryonic environment ventral to the adrenomedul- 
lary crest appears to elicit the chromaffin phenotype 
from cells that migrate into it. 
The effect of environment on the sympathoadrenal 
decision is apparent not only during development, but 
also in the "plasticity" of the fully differentiated deriv- 
atives. Thus, chromaffin cells, although expressing a 
terminally differentiated phenotype, retain the capac- 
ity to transdifferentiate into neurons both in vitro and 
in vivo, when exposed to nerve growth factor (NGF) 
(Unsicker et al. 1978; Aloe and Levi-Montalcini 1979; 
Doupe et al. 1985a,b). The in vitro conversion to a 
neural phenotype is blocked by glucocorticoids, ug- 
gesting that maintenance of the chromaffin phenotype 
may be a consequence of the ultimate location of the 
adrenal medullary cells, which are surrounded by ad- 
renal cortical cells expressing large quantities of glu- 
cocorticoids (Unsicker et al. 1978). Taken together, 
these and other observations have suggested that NGF 
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and glucocorticoids may play opposing roles in pro- 
moting the neural and chromaffin phenotypes, respec- 
tively, from a common precursor cell (Landis and Pat- 
terson 1981; Doupe et al. 1985b). This developmental 
decision therefore provides an opportunity to under- 
stand the molecular mechanisms that underlie the 
expression of alternative phenotypes by a multipoten- 
tial precursor, and the subsequent plasticity of these 
phenotypes, in response to defined environmental sig- 
nals. 
We have isolated cDNA clones for several mRNAs 
that are abundant in adult sympathetic neurons but not 
in adrenal chromaffin cells. Using RNA blot and in 
situ hybridization, we have analyzed the pattern of 
emergence of these messengers in embryonic develop- 
ment and their plasticity in cell culture. We find that 
these neural-specific genes are not synchronously in- 
duced but rather appear at recognizable stages in neu- 
rogenesis. Moreover, one of the genes is induced by 
NGF in PCI2 cells and in adrenal medullary primary 
cultures, suggesting that the hormone may control the 
transcriptional ctivation of this gene early in devel- 
opment. The results uggest a mechanism in which the 
developmental history of some of these neural-specific 
genes could account for their plasticity in mature chro- 
muffin cells. 
RESULTS 
The Appearance of Neural-specific mRNAs during 
Development 
We have isolated several cDNA clones encoding 
mRNA transcripts expressed in ganglionic neurons but 
not in adrenal chromaffin cells by performing differ- 
ential hybridization to a rat sympathetic ganglion 
cDNA library. The tissue-specificity of these clones was 
established by both Northern blot analysis and in situ 
hybridization. Clones SCG4, SCG5, and SCG10 detect 
abundant RNA species in both sympathetic ganglia nd 
brain, which are either absent or detectable at much 
lower levels in the adrenal medulla and in nonneural 
tissues (Fig. 1). In situ hybridization to sections and 
cultures of superior cervical ganglion, using single- 
stranded RNA probes (Cox et al. 1984), revealed grain 
accumulations over the cell bodies of principal neu- 
rons, but not over the nonneural cells within the gan- 
glion (data not shown). Consistent with the Northern 
analysis, no hybridization was observed to sections of 
adrenal chromaffin cells (Anderson and Axel 1985). 
855 
856 ANDERSON, STEIN, AND AXEL 
Figure 1. Tissue-specificity of clones SCG4, SCG5, and SCG10 expression. (A) Northern blots containing 10/zg/lane of total 
RNA from adult SCG (G, lanes 1), adrenal medulla (M, lanes 2), adrenal cortex (C, lanes 3) or 4-day postnatal SCG (G, lanes 
4), and whole adrenal (A, lanes 5) were hybridized with nick-translated probes as indicated below the panels. (B) As in A, except 
the lanes contained RNA from 6-day postnatal tissues: (B) brain; (H) heart; (K) kidney; (L) liver; (S) spleen. The probes used 
are indicated below the panels; "Actin" was a human 3-actin probe that detects asmaller cardiac actin transcription i  the heart 
RNA. All autoradiograms represent overnight exposures; we estimate the relative abundance of SCG4 and SCG10 in 4-day 
ganglia s 0.25 and 0.6%, respectively. 
The availability of neuron-specific clones that detect 
abundant mRNAs now permitted us to relate the ap- 
pearance of neural-specific mRNAs to the migratory 
events in neural crest differentiation. In the rat, neural 
crest cell migration begins around the ninth day of ges- 
tation (E9), proceeds along the embryo in a rostro-cau- 
dal gradient, and ends about EII.5-E12. At this stage, 
the sympathetic ganglia primordia have largely formed 
and consist of collections of primitive neuroblasts hat 
continue to divide throughout gestation, enlarging the 
ganglia (Hendry 1977; Rothman et al. 1978). The for- 
mation of the adrenal medulla occurs somewhat later 
via a secondary ventral migration of crest cells from 
the caudal thoracic region to a position above the kid- 
ney tubules where the cells coalesce with the mesoder- 
mally derived cortical cells. This secondary migration 
occurs beginning around El3 and continues until birth. 
A discrete adrenal medulla is visible by E17.5 (Bohn et 
al. 1981; Teitelman et al. 1982). 
In initial experiments we examined the develop- 
mental appearance of the neural-specific RNAs by per- 
forming Northern blot analyses on total embryo RNA. 
SCG5 mRNA is barely detectable between El0.5 and 
E13.5, but undergoes at least a 20-fold induction at 
birth. Thus, significant levels of SCG5 mRNA do not 
appear to accumulate in sympathetic neurons or the 
CNS until long after the cessation of neural crest mi- 
gration (Anderson and Axel 1985). In contrast to SCG5 
mRNA, SCG4 and SCGI0 mRNAs were both detect- 
able at significant levels in midgestational embryos, 
although their patterns of expression during devel- 
opment are distinct (Fig. 2). SCG10 mRNA is barely 
detectable at El0.5, but undergoes a 30-fold induction 
over the next 48 hours (Fig. 2A). During this period, 
SCG4 is expressed at fairly constant levels but then de- 
clines significantly beginning on about E13.5 (Fig. 2B). 
Regulated Expression f SCG10 
The temporal appearance of SCG 10 mRNA suggests 
that this gene is not expressed at high levels in the 
neural crest, but rather is induced in crest cells follow- 
ing migration and ganglion formation. To confirm this 
interpretation, we performed in situ hybridizations with 
an SCGI0 probe to embryo sections at various stages 
of development. In very caudal sections of Ell.5 era- 
MOLECULAR PROBES OF NEURAL CREST DEVELOPMENT 857 
Figure 2. Early expression of SCG10 and SCG4 mRNAs. To- 
tal cellular RNA (10 ttg) isolated from embryos of the stages 
indicated was subjected to Northern analysis as described in 
Methods. Blots were hybridized with 32P-labeled SP6 RNA 
probes labeled to a specific activity of 4 x 109 dpm/~tg. Blots 
A and B were exposed for different times and therefore the 
signal intensities are not directly comparable. (A) SCG10 
probe; (B) SCG4 probe. 
bryos, significant hybridization is observed to the neu- 
rons of the ventrolateral neural tube, but not o cells in 
the migrating neural crest (Fig. 3D). In more rostral 
sections of the same embryo (Fig. 3B,C), much higher 
grain densities were apparent in the ventral and lateral 
margins of the neural tube, suggesting that expression 
of SCG10 mRNA occurs in the neural tube in a rostro- 
caudal gradient. Later, at E13.5, SCG 10 transcripts were 
detectable at high levels in the sympathetic and sensory 
ganglia (Fig. 4A) and in parasympathetic primordia in 
the arterial walls (Fig. 4B). However, no hybridization 
is observed with the ependymal zone of the neural tube 
which contains mitotic undifferentiated neuroblasts 
(Fig. 4A). Thus, in both the central and peripheral 
nervous system, expression of SCG10 mRNA corre- 
lates with the earliest overt signs of commitment to a 
neuronal phenotype, occurring first in the ventrola- 
teral neural tube and later in the peripheral ganglion 
primordia. 
Comparison of the intensity of grains over develop- 
ing ganglia suggest hat a large component of the in- 
duction seen on Northern blots is likely to be due to an 
increase in the proportion of embryonal cells which are 
neurons as the consequence of either mitotic expansion 
(Rothman et al. 1978) or conversion of cells. Quantita- 
tively, however, a 30-fold relative increase in the neural 
population (needed to account for the magnitude of 
SCG10 mRNA induction) would exceed that actually 
generated in this 48-hour interval, so that induction is 
probably occurring on a per cell basis as well. In sup- 
port of this, we observe an increase in grain density 
between Ell.5 and E13.5 in the ventrolateral neural 
tube. 
The observation that SCGI0 mRNA appears in sym- 
pathetic neurons ubsequent to neural crest migration 
next led us to ask whether any known environmental 
factors could influence the expression of this gene. 
Previous studies have suggested that the choice of a 
neuronal phenotype by sympathoadrenal precursors 
may be influenced by NGF in the cell's local environ- 
ment (Unsicker et al. 1978; Aloe and Levi-Montalcini 
1979; Landis and Patterson 1981; Doupe et al. 1985b). 
We therefore xamined the ability of this polypeptide 
hormone to influence levels of SCG10 mRNA in vitro. 
We observed that SCG10 mRNA was induced almost 
10-fold by NGF in PCI2 cells (Fig. 5A), an adrenal 
medullary pheochromocytoma tumor line (Greene and 
Tischler 1976) that has many properties of a committed 
adrenergic precursor and which responds to NGF with 
neurite outgrowth. This induction is also observed in 
primary cultures of dissociated neonatal adrenal chro- 
maffin cells exposed to NGE In situ hybridization to 
adrenal chromaffin cell cultures in the presence of NGF 
revealed that those cells that converted to a neuronal 
morphology (Unsicker et al. 1978; Naujoks et al. 1982; 
Ogawa et al. 1984; Doupe et al. 1985a) also expressed 
SCG10 mRNA at high levels (Fig. 6A,B). 
Thus, SCG10 mRNA is induced by NGF exposure in 
both primary cultures of chromaffin cells and in an 
established pheochromocytoma cell line. These results 
suggest that the dramatic appearance of this RNA early 
in the development of sensory and sympathetic neu- 
rons may result from the migration of these cells to an 
environment containing high local concentrations of
NGF, or from the synchronous appearance of NGF in 
the embryo. 
The Regulated Expression f SCG4 
The pattern of expression of SCG4 mRNA during 
development is distinct from that of SCG10. SCG4 
mRNA is highly enriched in adult neurons. Early in 
development, however, this RNA is abundant in vir- 
tually all tissues of the embryo. Expression of SCG4 
mRNA declines precipitously in all tissues during late 
gestation but then returns to high levels after birth, 
specifically in the nervous ystem. Northern blot anal- 
ysis of total embryo RNA reveals that SCG4 mRNA is 
expressed as an abundant species in midgestational 
embryos and is already quite abundant at E10.5, a time 
when SCGI0 mRNA is barely detectable (Fig. 2B). This 
RNA is maintained at high levels (~10 times the abun- 
dance of SCG10) until E14 and then declines gradually 
to low levels at birth. In situ hybridizations yielded an 
unexpected result: although the SCG4 mRNA was 
clearly abundant in sympathetic ganglia, dorsal root 
ganglia, and the neural tube, hybridization was also 
detected in several other nonneural tissues, particularly 
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Figure 3. In situ distribution ofSCG10 mRNA at stage 
Ell.5. Sections obtained from a single embryo series 
were hybridized in situ with 3sS-labeled SP6 RNA tran- 
scripts from clone 10and are displayed as bright- 
field-dark-field pairs. The sections proceed from A t  
D in a rostral to caudal direction. Sections are trans- 
verse but slightly oblique, thus structures ventral o the 
neural tube in a given section appear slightly more cau- 
dal in characteristics. (A) Region of the myelenceph- 
alon (MY). A cranial ganglion (CG) is visible ventral 
to the anterior cardinal vein (ACV) and dorsolateral to 
the internal carotid artery (ICA), which shows strong 
hybridization signal in dark field. Note also the high 
grain density in the ventrolateral nearal tube. (PH) 
Pharynx. (B) Region of the posterior myelencephalon. 
(DA) Dorsal aorta; (NT) neural tube; (PCV) posterior 
cardinal vein; (PC) pleural cavity; (LB) lung bud. (C) 
Trunk region. Due to the curvature of the embryo, this 
section shows a more tangential appearance. (NT) 
Neural tube; (DRG) dorsal root ganglia; (DA) dorsal 
aorta; (*) putative sympathetic ganglion primordium. 
Note the relative absence of grains over this structure 
relative to the ventrolateral neural tube and the lateral 
aspect of the DRG. (D) More caudal region. Migrating 
neural crest cells (NC) are visible between the neural 
tube and a somite, which is divided into dermomy- 
otome (DMT) and scelerotome (SC) regions. (DA) 
Dorsal aorta; (EC) ectoderm. B and D were hybridized 
in parallel and thus the grain densities are directly 
comparable. Exposure times were 3-4 days. Magnifi- 
cations: A, 36• ; B and C, 45 • ; D, 93 x. 
the lung (not shown). Northern blot analysis however 
confirmed this observation: SCG4 mRNA is abundant 
in heart, kidney, liver, lung, adrenal, and brain from 
Et6 embryos (Fig. 7), declines neonatally, and reap- 
pears postnatally in neurons. 
If, as we have suggested previously, the induction of 
clone 10 is in part mediated by the appearance of NGF, 
we would not predict hat the expression of clone 4 is 
also mediated by NGF, as it is not coordinately ex- 
pressed in time with clone 10 and, more importantly, it 
is expressed at high levels in tissues uch as lung and 
heart which are not thought o contain NGF receptors. 
Indeed, we observed that SCG4 mRNA is expressed at 
high levels in naive P12 cells and is not affected by NGF 
treatment (Fig. 5B). This finding was therefore consis- 
tent with the presumed embryonic origin of this cell 
line. A different result is obtained when primary adre- 
nal chromaffin cells are exposed to NGF. Chromaffin 
cells cultured from 7-day postnatal animals exhibited 
little or no in situ hybridization signals over back- 
ground with an SCG4 probe (Fig. 6A, bottom), a find- 
ing consistent with previous data from Northern blot 
analyses (cf. Fig. 1). When similar cultures were then 
exposed to nerve growth factor for 1 month, those cells 
that morphologically converted to a neural phenotype 
showed strong hybridization signals (Fig. 6B, bottom) 
similar in intensity to that observed for bona fide sym- 
pathetic neurons treated in parallel (not shown). 
These results suggest that the expression of clone 4 
mRNA may be regulated by distinct mechanisms at 
different imes in development. Early in embryogene- 
sis, a high level of constitutive synthesis of clone 4 RNA 
is observed in a host of neural and nonneural tissues 
and this synthesis i unlikely to be regulated by NGF. 
Postnatally, the expression of clone 4 declines in all tis- 
sues and increases olely in tissues of neural origin 
where its expression may be regulated by exposure to 
NGE 
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Figure 4. In situ distribution of SCG10 at later stages of development. (A) Section hrough trunk region E13.5. Note intense 
hybridization to neural tube (NT), dorsal root ganglia (DRG), and sympathetic ganglia (SG), while the ependymal zone (EZ) 
containing undifferentiated neuroblasts is negative. (NC) Notochord; (DA) dorsal aorta; (ACV) anterior cardinal vein. Magni- 
fication, 40 x. (B) Section through ventral trunk El5. (DA) Dorsal aorta; (LU) lung; (BA) bulbus arteriosus; (LA) left atrium; 
(LV) left ventricle. Note strong signal to putative parasympathetic ganglia (PSG) surrounding the pulmonary artery (PA). The 
circular white spot in dark field (right panel) isan artifact. 
DISCUSSION 
Regulated Expression f Specific RNAs during Neural 
Development 
We have followed the emergence of neurons during 
developmental time by performing in situ and blot hy- 
bridization with three neural-specific eDNA probes. 
Our data suggest hat the induction of neural-specific 
genes does not occur synchronously but rather occurs 
in at least two major stages in vertebrate neurogenesis, 
one coinciding with the earliest overt signs of commit- 
ment to a neural phenotype (SCG 10) and the other cor- 
responding to maturation events that occur early in 
postnatal life (SCG4 and SCG5). 
The observation that each clone appears at different 
times in development raises the question of what fac- 
tors control these patterns of expression. NGF has pre- 
viously been implicated in the chromaffin-neuron 
decision that occurs early in development (Aloe and 
Levi-Montalcini 1979; Landis and Patterson 1981). 
Clone SCG10 was inducible by NGF both in primary 
cultures of neonatal chromaffin ceils and in the NGF- 
responsive pheochromocytoma tumor cell line PCI2. It 
is therefore possible that NGF may be responsible for 
Figure 6. (See facing page for legend.) 
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the transcriptional ctivation of SCGI0 mRNA in sen- 
sory and sympathetic neurons during early develop- 
ment. This induction may be a consequence of the ap- 
pearance of NGF, NGF receptors, or alternatively, the 
migration of crest cells to an environment enriched in 
NGE However, we also observe ubiquitous expression 
of SCG10 mRNA in parasympathetic and central neu- 
rons, most of which are not responsive to NGF by clas- 
sical criteria. We therefore think it unlikely that NGF 
is the sole mediator of SCGI0 mRNA induction in the 
central and peripheral nervous ystem. Rather, expres- 
sion of SCGI0 mRNA may be controlled by different 
factors in different ypes of neurons. 
SCG4 mRNA was also induced by NGF in postnatal 
chromaffin cells, but was constitutively expressed by 
PCI2 cells. Our in situ hybridization data for SCG4 
indicated that in the embryo it is abundant in both 
neural and nonneural cells, but is then extinguished and 
reexpressed selectively in neurons after birth. The NGF 
induction of SCG4 in chromaffin cells may thus reflect 
the reexpression of the gene that normally occurs in 
neurons of the same age. Likewise, the high level of 
expression of SCG4 mRNA in PCI2 cells is consistent 
with the presumed embryonic ature of this tumor cell 
line (Greene and Tischler 1976). 
The observation that glucocorticoids inhibit the 
NGF-induced conversion of chromaffin cells to neu- 
rons has led to the suggestion that these hormones may 
promote endocrine differentiation by blocking the 
NGF-induced expression of the neuronal phenotype by 
embryonic adrenal medullary pheochromoblasts. Pre- 
liminary in situ hybridization data suggest that, at E 14, 
SCG10 mRNA is not expressed by, or is present at low 
levels in, immature chromaffin cells compared to 
neighboring sympathetic neurons (not shown.) Yet, the 
adrenal cortex does not secrete glucocorticoids until 
E17 (Bohn et al. 1981). The implication is that adrenal 
Figure 5. SCG10 mRNA is induced by NGF in PCI2 cells. 
PC 12 cells, at ~0.5-1.0 x l0 ~ cells/10-cm dish, were treated 
for 4 days with medium containing no additives (lanes 
CON), 5 ttM dexamethasone (lanes DEX), or 50 #g/ml/3- 
NGF (lanes NGF). Shown are three identical Northern 
blots containing 10 #g/lane of total RNA prepared from 
the indicated cultures. Probes used were SCG10 (A), SCG4 
(B), or human 7-actin (C). A and B were hybridized with 
3zP-labeled SP6 probes of the same specific activity, and 
the blot was exposed for the same length of time to show 
the relative abundance of the two mRNAs. 
environmental factors other than glucocorticoids may 
suppress (or permit only transient, low-level) expres- 
sion of SCG10 mRNA by E14 pheochromoblasts. Con- 
sistent with this, dexamethasone only weakly ('~two- 
fold) inhibited NGF induction of SCG10 mRNA in 
PC12 cells (not shown), and had no apparent effect on 
neurite outgrowth from organ-cultured El7 adrenal 
glands (Unsicker et al. 1985). In vivo, then, glucocor- 
ticoids may serve to maintain the differentiated chro- 
muffin phenotype rather than to prevent initial differ- 
entiation of pheochromoblasts along the neuronal 
pathway. 
Molecular Mechanism of Chromaffin Cell Plasticity 
Chromaffin cells, expressing the phenotype of a ma- 
ture endocrine cell, convert at high frequency to a neu- 
ronal phenotype both in vitro and in vivo in response 
to NGF (Unsicker et al. 1978; Aloe and Levi-Montal- 
cini 1979; Doupe et al. 1985a). Our data illustrate this 
phenotypic plasticity at the level of RNA: mRNAs 
whose expression is normally restricted to neurons are 
induced to high levels in chromaffin cells exposed to 
NGE Although the induction of neural-specific 
mRNAs by NGF in primary chromaffin cells may dif- 
fer mechanistically from their initial induction in vivo, 
we believe that the plasticity of these genes in response 
to NGF nevertheless i a consequence of develop- 
mental changes in their chromatin structure in the 
sympathoadrenal precursor. 
Specifically, the common precursor may maintain a 
battery of genes, specific to either sympathetic neurons 
or chromaffin cells, in an "open" chromatin configu- 
ration that is poised for transcription (Groudine and 
Weintraub 1982). The selection of those genes to be ex- 
pressed would depend upon environmental signals, 
such as NGF or glucocorticoids, encountered by the 
Figure 6. SCGI0 and SCG4 mRNAs are induced by NGF in primary chromaffin cells. Shown are phase/dark-field pairs of in 
situ hybridizations to cultured cells. (Top) SCG10 probe; (bottom) SCG4 probe. (A) Chromaffin cells (CHR) grown in 5 /zM 
dexamethasone. Note fibroblastic flat cells (FL) that are also negative with both probes. (B) Chromaffin cells switched after 1 
week in dexamethasone to medium containing 50 ng/ml NGF and 10 -5 M each of cytosine arabinoside and fluorodeoxyuridine. 
Cultures were maintained in this medium for 3 weeks prior to fixation. The photomicrographs arefocused on the upper surface 
of the cells and thus the background is out of focus. Magnification, 215 x. 
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Figure 7. Developmental regulation of SCG4 mRNA. (A) Expression of SCG4 mRNA in nonneural tissues from El6 embryos. 
Each lane contains 10 #g of total RNA from adrenal gland (lane A), heart (lane/-/), kidney (lane K), liver (lane Lv), lung (lane 
L), and brain (lane B). Compare with Fig. lB. (B and C) SCG4 mRNA declines in late gestation and is reexpressed selectively in 
nervous tissue. (B) Each lane contains 10 p.g of total RNA from adrenal glands of the ages indicated. The amount detectable in 
adult (Ad) tissue corresponds to ,~30-40 copies of mRNA/cell, assuming 2 • 105 mRNA molecules/cell. (C) RNA from devel- 
oping superior cervical ganglion (SCG). Adult levels correspond toabout 1400 copies/cell. 
cell during or after migration. The inducibility of 
neural-specific genes in chromaffin cells may therefore 
reflect the persistence of these genes in such a tran- 
scriptionally competent configuration, despite the fact 
that they are not expressed as part of the mature chro- 
maffin phenotype. In support of this model, studies of 
the structure of several tissue-specific genes have dem- 
onstrated that a nuclease-sensitive, "open" chromatin 
configuration developmentally precedes active tran- 
scription (Hofer et al. 1982; Sheffery et al. 1982; Butch 
and Weintraub 1983). In this way, the precursor may 
actively differentiate along one pathway while retain- 
ing the potential to switch to another pathway in re- 
sponse to a changed environment. 
Why Have Plasticity? 
The cells of the neural crest undergo extensive migra- 
tions before terminally differentiating into derivatives 
of widely varying phenotypes. The migratory pathways 
followed by neural crest cells are complex and may de- 
pend largely upon the cell's starting position (Le- 
Douarin 1982; Thiery et al. 1982). While "homing" 
mechanisms may play a role in specifying a crest cell's 
final destination i advance of migration, the available 
data nevertheless suggest he process involves a fair 
amount of chance and randomness. If the ultimate n- 
vironment of a crest cell cannot be completely deter- 
mined in advance of migration, and this environment 
determines the cell's fate, then premigratory neural 
crest cells must face considerable developmental uncer- 
tainty. The multipotentiality apparent within the sym- 
pathoadrenal lineage, at least, constitutes one evolu- 
tionary strategy for accommodating this uncertainty. 
This multipotentiality may be exploited to generate the 
phenotypic diversity displayed by the nervous system, 
and its persistence may permit changes in neuronal 
phenotypes in the mature organism (Furshpan et al. 
1976; Patterson 1978; Black 1982; Landis and Keefe 
1983; Black et al. 1984; Doupe et al, 1985a). 
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